1. Home /
  2. Drug Approvals

Drug Approvals

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

AbbVie's Quant Upgrade Gets My Attention. Bullish Charts Keep It

With two approaches on the same page, here's how we'd trade this drugmaker's stock.

Who Would Bet Against Eli Lilly? I Would and Here's How

Let me show you an options play and tell why now could be the time to use it.

As Novo Nordisk Surges on Ozempic, Wegovy, Is the Stock Looking a Little Heavy?

Unbelievably, there may be more interest in weight loss than AI right now.

I Like This Small-Cap Stock Long-Term: This Is How I'll Trade It

It's small-cap earnings season and the market is under pressure. This may create some good opportunities.

Eli Lilly Soars as Mounjaro, Growth Products Take Off: We're Upping Our Target

Here's how traders can play the stock.

Sage Therapeutics Shares Plunge After FDA Rejection

Is this a buy the dip move?

2 Biotech Stocks to Watch as Their Growth Stories Brighten

These small and mid-cap names have seen major news of late.

Abbott Laboratories Has Rallied Towards a Major Breakout Area

As we check the charts, I have two new price targets.

Let's Check the Safety and Efficacy of Amgen's Charts Ahead of Earnings

AMGN's quarterly report is due in early August, so will buying the stock now pose any side effects?